The global Oral Codeine Tablet market size was valued at USD 701.2 million in 2023 and is forecast to a readjusted size of USD 978.9 million by 2030 with a CAGR of 4.9% during review period.
Codeine is an opiate used to treat pain, coughing, and diarrhea. It is typically used to treat mild to moderate degrees of pain.
The Codeine Narcotic market is driven by the demand for effective pain management and the widespread use of codeine as an analgesic and antitussive medication. Codeine, a narcotic drug derived from opium, is prescribed to alleviate moderate to severe pain and suppress coughing. The prevalence of conditions causing pain, such as post-surgery recovery and chronic illnesses, contributes to market growth as healthcare professionals seek safe and accessible pain relief options. Moreover, codeine's relatively lower potential for abuse compared to other narcotics aligns with its continued medical use. However, the market also faces challenges, including the potential for misuse and addiction due to codeine's opioid properties, leading to regulatory controls and prescription limitations in various regions. Additionally, addressing patient education about codeine's potential risks and benefits, and ensuring proper dosing and monitoring can pose obstacles for healthcare providers. To succeed, pharmaceutical companies must focus on responsible prescribing practices, patient education, and addressing the challenges to ensure the appropriate use of codeine while providing effective pain management solutions that prioritize patient safety.
Report includes an overview of the development of the Oral Codeine Tablet industry chain, the market status of Narcotic Analgesic (Single-ingredient Codeine, Multi-ingredient Medications), Antitussive (Single-ingredient Codeine, Multi-ingredient Medications), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Oral Codeine Tablet.
Regionally, the report analyzes the Oral Codeine Tablet markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Oral Codeine Tablet market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Oral Codeine Tablet market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Oral Codeine Tablet industry.
The report involves analyzing the market at a macro level:
麻豆原创 Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Single-ingredient Codeine, Multi-ingredient Medications).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Oral Codeine Tablet market.
Regional Analysis: The report involves examining the Oral Codeine Tablet market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
麻豆原创 Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Oral Codeine Tablet market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Oral Codeine Tablet:
Company Analysis: Report covers individual Oral Codeine Tablet manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Oral Codeine Tablet This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Narcotic Analgesic, Antitussive).
Technology Analysis: Report covers specific technologies relevant to Oral Codeine Tablet. It assesses the current state, advancements, and potential future developments in Oral Codeine Tablet areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Oral Codeine Tablet market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
麻豆原创 Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
麻豆原创 Segmentation
Oral Codeine Tablet market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
麻豆原创 segment by Type
Single-ingredient Codeine
Multi-ingredient Medications
麻豆原创 segment by Application
Narcotic Analgesic
Antitussive
Others
Major players covered
Taiji
Mallinckrodt
TEVA
Johnson & Johnson
Medreich
Sanofi Aventis
Cipla
Hikma
Pharmaceutical Associates
Novartis
Apotex
Mylan
Aristo Pharma GmbH
Lannett Company
Laboratoire Riva
麻豆原创 segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Oral Codeine Tablet product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Oral Codeine Tablet, with price, sales, revenue and global market share of Oral Codeine Tablet from 2019 to 2024.
Chapter 3, the Oral Codeine Tablet competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Oral Codeine Tablet breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Oral Codeine Tablet market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Oral Codeine Tablet.
Chapter 14 and 15, to describe Oral Codeine Tablet sales channel, distributors, customers, research findings and conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.
1 麻豆原创 Overview
1.1 Product Overview and Scope of Oral Codeine Tablet
1.2 麻豆原创 Estimation Caveats and Base Year
1.3 麻豆原创 Analysis by Type
1.3.1 Overview: Global Oral Codeine Tablet Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Single-ingredient Codeine
1.3.3 Multi-ingredient Medications
1.4 麻豆原创 Analysis by Application
1.4.1 Overview: Global Oral Codeine Tablet Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Narcotic Analgesic
1.4.3 Antitussive
1.4.4 Others
1.5 Global Oral Codeine Tablet 麻豆原创 Size & Forecast
1.5.1 Global Oral Codeine Tablet Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Oral Codeine Tablet Sales Quantity (2019-2030)
1.5.3 Global Oral Codeine Tablet Average Price (2019-2030)
2 Manufacturers Profiles
2.1 Taiji
2.1.1 Taiji Details
2.1.2 Taiji Major Business
2.1.3 Taiji Oral Codeine Tablet Product and Services
2.1.4 Taiji Oral Codeine Tablet Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.1.5 Taiji Recent Developments/Updates
2.2 Mallinckrodt
2.2.1 Mallinckrodt Details
2.2.2 Mallinckrodt Major Business
2.2.3 Mallinckrodt Oral Codeine Tablet Product and Services
2.2.4 Mallinckrodt Oral Codeine Tablet Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.2.5 Mallinckrodt Recent Developments/Updates
2.3 TEVA
2.3.1 TEVA Details
2.3.2 TEVA Major Business
2.3.3 TEVA Oral Codeine Tablet Product and Services
2.3.4 TEVA Oral Codeine Tablet Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.3.5 TEVA Recent Developments/Updates
2.4 Johnson & Johnson
2.4.1 Johnson & Johnson Details
2.4.2 Johnson & Johnson Major Business
2.4.3 Johnson & Johnson Oral Codeine Tablet Product and Services
2.4.4 Johnson & Johnson Oral Codeine Tablet Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.4.5 Johnson & Johnson Recent Developments/Updates
2.5 Medreich
2.5.1 Medreich Details
2.5.2 Medreich Major Business
2.5.3 Medreich Oral Codeine Tablet Product and Services
2.5.4 Medreich Oral Codeine Tablet Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.5.5 Medreich Recent Developments/Updates
2.6 Sanofi Aventis
2.6.1 Sanofi Aventis Details
2.6.2 Sanofi Aventis Major Business
2.6.3 Sanofi Aventis Oral Codeine Tablet Product and Services
2.6.4 Sanofi Aventis Oral Codeine Tablet Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.6.5 Sanofi Aventis Recent Developments/Updates
2.7 Cipla
2.7.1 Cipla Details
2.7.2 Cipla Major Business
2.7.3 Cipla Oral Codeine Tablet Product and Services
2.7.4 Cipla Oral Codeine Tablet Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.7.5 Cipla Recent Developments/Updates
2.8 Hikma
2.8.1 Hikma Details
2.8.2 Hikma Major Business
2.8.3 Hikma Oral Codeine Tablet Product and Services
2.8.4 Hikma Oral Codeine Tablet Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.8.5 Hikma Recent Developments/Updates
2.9 Pharmaceutical Associates
2.9.1 Pharmaceutical Associates Details
2.9.2 Pharmaceutical Associates Major Business
2.9.3 Pharmaceutical Associates Oral Codeine Tablet Product and Services
2.9.4 Pharmaceutical Associates Oral Codeine Tablet Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.9.5 Pharmaceutical Associates Recent Developments/Updates
2.10 Novartis
2.10.1 Novartis Details
2.10.2 Novartis Major Business
2.10.3 Novartis Oral Codeine Tablet Product and Services
2.10.4 Novartis Oral Codeine Tablet Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.10.5 Novartis Recent Developments/Updates
2.11 Apotex
2.11.1 Apotex Details
2.11.2 Apotex Major Business
2.11.3 Apotex Oral Codeine Tablet Product and Services
2.11.4 Apotex Oral Codeine Tablet Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.11.5 Apotex Recent Developments/Updates
2.12 Mylan
2.12.1 Mylan Details
2.12.2 Mylan Major Business
2.12.3 Mylan Oral Codeine Tablet Product and Services
2.12.4 Mylan Oral Codeine Tablet Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.12.5 Mylan Recent Developments/Updates
2.13 Aristo Pharma GmbH
2.13.1 Aristo Pharma GmbH Details
2.13.2 Aristo Pharma GmbH Major Business
2.13.3 Aristo Pharma GmbH Oral Codeine Tablet Product and Services
2.13.4 Aristo Pharma GmbH Oral Codeine Tablet Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.13.5 Aristo Pharma GmbH Recent Developments/Updates
2.14 Lannett Company
2.14.1 Lannett Company Details
2.14.2 Lannett Company Major Business
2.14.3 Lannett Company Oral Codeine Tablet Product and Services
2.14.4 Lannett Company Oral Codeine Tablet Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.14.5 Lannett Company Recent Developments/Updates
2.15 Laboratoire Riva
2.15.1 Laboratoire Riva Details
2.15.2 Laboratoire Riva Major Business
2.15.3 Laboratoire Riva Oral Codeine Tablet Product and Services
2.15.4 Laboratoire Riva Oral Codeine Tablet Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.15.5 Laboratoire Riva Recent Developments/Updates
3 Competitive Environment: Oral Codeine Tablet by Manufacturer
3.1 Global Oral Codeine Tablet Sales Quantity by Manufacturer (2019-2024)
3.2 Global Oral Codeine Tablet Revenue by Manufacturer (2019-2024)
3.3 Global Oral Codeine Tablet Average Price by Manufacturer (2019-2024)
3.4 麻豆原创 Share Analysis (2023)
3.4.1 Producer Shipments of Oral Codeine Tablet by Manufacturer Revenue ($MM) and 麻豆原创 Share (%): 2023
3.4.2 Top 3 Oral Codeine Tablet Manufacturer 麻豆原创 Share in 2023
3.4.2 Top 6 Oral Codeine Tablet Manufacturer 麻豆原创 Share in 2023
3.5 Oral Codeine Tablet 麻豆原创: Overall Company Footprint Analysis
3.5.1 Oral Codeine Tablet 麻豆原创: Region Footprint
3.5.2 Oral Codeine Tablet 麻豆原创: Company Product Type Footprint
3.5.3 Oral Codeine Tablet 麻豆原创: Company Product Application Footprint
3.6 New 麻豆原创 Entrants and Barriers to 麻豆原创 Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Oral Codeine Tablet 麻豆原创 Size by Region
4.1.1 Global Oral Codeine Tablet Sales Quantity by Region (2019-2030)
4.1.2 Global Oral Codeine Tablet Consumption Value by Region (2019-2030)
4.1.3 Global Oral Codeine Tablet Average Price by Region (2019-2030)
4.2 North America Oral Codeine Tablet Consumption Value (2019-2030)
4.3 Europe Oral Codeine Tablet Consumption Value (2019-2030)
4.4 Asia-Pacific Oral Codeine Tablet Consumption Value (2019-2030)
4.5 South America Oral Codeine Tablet Consumption Value (2019-2030)
4.6 Middle East and Africa Oral Codeine Tablet Consumption Value (2019-2030)
5 麻豆原创 Segment by Type
5.1 Global Oral Codeine Tablet Sales Quantity by Type (2019-2030)
5.2 Global Oral Codeine Tablet Consumption Value by Type (2019-2030)
5.3 Global Oral Codeine Tablet Average Price by Type (2019-2030)
6 麻豆原创 Segment by Application
6.1 Global Oral Codeine Tablet Sales Quantity by Application (2019-2030)
6.2 Global Oral Codeine Tablet Consumption Value by Application (2019-2030)
6.3 Global Oral Codeine Tablet Average Price by Application (2019-2030)
7 North America
7.1 North America Oral Codeine Tablet Sales Quantity by Type (2019-2030)
7.2 North America Oral Codeine Tablet Sales Quantity by Application (2019-2030)
7.3 North America Oral Codeine Tablet 麻豆原创 Size by Country
7.3.1 North America Oral Codeine Tablet Sales Quantity by Country (2019-2030)
7.3.2 North America Oral Codeine Tablet Consumption Value by Country (2019-2030)
7.3.3 United States 麻豆原创 Size and Forecast (2019-2030)
7.3.4 Canada 麻豆原创 Size and Forecast (2019-2030)
7.3.5 Mexico 麻豆原创 Size and Forecast (2019-2030)
8 Europe
8.1 Europe Oral Codeine Tablet Sales Quantity by Type (2019-2030)
8.2 Europe Oral Codeine Tablet Sales Quantity by Application (2019-2030)
8.3 Europe Oral Codeine Tablet 麻豆原创 Size by Country
8.3.1 Europe Oral Codeine Tablet Sales Quantity by Country (2019-2030)
8.3.2 Europe Oral Codeine Tablet Consumption Value by Country (2019-2030)
8.3.3 Germany 麻豆原创 Size and Forecast (2019-2030)
8.3.4 France 麻豆原创 Size and Forecast (2019-2030)
8.3.5 United Kingdom 麻豆原创 Size and Forecast (2019-2030)
8.3.6 Russia 麻豆原创 Size and Forecast (2019-2030)
8.3.7 Italy 麻豆原创 Size and Forecast (2019-2030)
9 Asia-Pacific
9.1 Asia-Pacific Oral Codeine Tablet Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Oral Codeine Tablet Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Oral Codeine Tablet 麻豆原创 Size by Region
9.3.1 Asia-Pacific Oral Codeine Tablet Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Oral Codeine Tablet Consumption Value by Region (2019-2030)
9.3.3 China 麻豆原创 Size and Forecast (2019-2030)
9.3.4 Japan 麻豆原创 Size and Forecast (2019-2030)
9.3.5 Korea 麻豆原创 Size and Forecast (2019-2030)
9.3.6 India 麻豆原创 Size and Forecast (2019-2030)
9.3.7 Southeast Asia 麻豆原创 Size and Forecast (2019-2030)
9.3.8 Australia 麻豆原创 Size and Forecast (2019-2030)
10 South America
10.1 South America Oral Codeine Tablet Sales Quantity by Type (2019-2030)
10.2 South America Oral Codeine Tablet Sales Quantity by Application (2019-2030)
10.3 South America Oral Codeine Tablet 麻豆原创 Size by Country
10.3.1 South America Oral Codeine Tablet Sales Quantity by Country (2019-2030)
10.3.2 South America Oral Codeine Tablet Consumption Value by Country (2019-2030)
10.3.3 Brazil 麻豆原创 Size and Forecast (2019-2030)
10.3.4 Argentina 麻豆原创 Size and Forecast (2019-2030)
11 Middle East & Africa
11.1 Middle East & Africa Oral Codeine Tablet Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Oral Codeine Tablet Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Oral Codeine Tablet 麻豆原创 Size by Country
11.3.1 Middle East & Africa Oral Codeine Tablet Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Oral Codeine Tablet Consumption Value by Country (2019-2030)
11.3.3 Turkey 麻豆原创 Size and Forecast (2019-2030)
11.3.4 Egypt 麻豆原创 Size and Forecast (2019-2030)
11.3.5 Saudi Arabia 麻豆原创 Size and Forecast (2019-2030)
11.3.6 South Africa 麻豆原创 Size and Forecast (2019-2030)
12 麻豆原创 Dynamics
12.1 Oral Codeine Tablet 麻豆原创 Drivers
12.2 Oral Codeine Tablet 麻豆原创 Restraints
12.3 Oral Codeine Tablet Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
13.1 Raw Material of Oral Codeine Tablet and Key Manufacturers
13.2 Manufacturing Costs Percentage of Oral Codeine Tablet
13.3 Oral Codeine Tablet Production Process
13.4 Oral Codeine Tablet Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Oral Codeine Tablet Typical Distributors
14.3 Oral Codeine Tablet Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
Taiji
Mallinckrodt
TEVA
Johnson & Johnson
Medreich
Sanofi Aventis
Cipla
Hikma
Pharmaceutical Associates
Novartis
Apotex
Mylan
Aristo Pharma GmbH
Lannett Company
Laboratoire Riva
听
听
*If Applicable.
